Tags

Type your tag names separated by a space and hit enter

Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry.
Biomed Chromatogr. 2005 Jun; 19(5):355-61.BC

Abstract

An assay for the quantitative determination of docetaxel in human plasma is described. Docetaxel was extracted from the matrix using liquid-liquid extraction with ter-butylmethylether, followed by high-performance liquid chromatographic analysis using an alkaline eluent. Paclitaxel was used as internal standard. Positive ionization electrospray tandem mass spectrometry was performed for selective and sensitive detection. The method was validated according to the FDA guidelines on bioanalytical method validation. The validated range for docetaxel was from 0.25--1000 ng/mL using 200 microL plasma aliquots. The method requires only a limited volume (200 microL) of human plasma and the method can be applied in studies requiring a low lower limit of quantitation of 0.25 ng/mL. The assay was applied successfully in several clinical and pharmacological studies with docetaxel.

Authors+Show Affiliations

Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands. i.kuppens@nki.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Validation Study

Language

eng

PubMed ID

15586372

Citation

Kuppens, I E L M., et al. "Quantitative Analysis of Docetaxel in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry." Biomedical Chromatography : BMC, vol. 19, no. 5, 2005, pp. 355-61.
Kuppens IE, van Maanen MJ, Rosing H, et al. Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry. Biomed Chromatogr. 2005;19(5):355-61.
Kuppens, I. E., van Maanen, M. J., Rosing, H., Schellens, J. H., & Beijnen, J. H. (2005). Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry. Biomedical Chromatography : BMC, 19(5), 355-61.
Kuppens IE, et al. Quantitative Analysis of Docetaxel in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry. Biomed Chromatogr. 2005;19(5):355-61. PubMed PMID: 15586372.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry. AU - Kuppens,I E L M, AU - van Maanen,M J, AU - Rosing,H, AU - Schellens,J H M, AU - Beijnen,J H, PY - 2004/12/9/pubmed PY - 2005/12/13/medline PY - 2004/12/9/entrez SP - 355 EP - 61 JF - Biomedical chromatography : BMC JO - Biomed Chromatogr VL - 19 IS - 5 N2 - An assay for the quantitative determination of docetaxel in human plasma is described. Docetaxel was extracted from the matrix using liquid-liquid extraction with ter-butylmethylether, followed by high-performance liquid chromatographic analysis using an alkaline eluent. Paclitaxel was used as internal standard. Positive ionization electrospray tandem mass spectrometry was performed for selective and sensitive detection. The method was validated according to the FDA guidelines on bioanalytical method validation. The validated range for docetaxel was from 0.25--1000 ng/mL using 200 microL plasma aliquots. The method requires only a limited volume (200 microL) of human plasma and the method can be applied in studies requiring a low lower limit of quantitation of 0.25 ng/mL. The assay was applied successfully in several clinical and pharmacological studies with docetaxel. SN - 0269-3879 UR - https://www.unboundmedicine.com/medline/citation/15586372/Quantitative_analysis_of_docetaxel_in_human_plasma_using_liquid_chromatography_coupled_with_tandem_mass_spectrometry_ DB - PRIME DP - Unbound Medicine ER -